ADVERTISEMENT
  • News
  • Technology
  • Culture
  • Entertainment
  • Sport
  • Travel
  • Music
  • More
    • Politics
    • Lifestyle
    • TV
    • Games
Wednesday, May 31, 2023
  • Login
No Result
View All Result
NEWSLETTER
FINCHANNEL
  • Home
  • Business
    • BANKS
      • GeoBanks
    • Finance
    • Insurance
    • Markets
    • Pharmacy
    • Press Releases
    • RealEstate
    • RealEstate
    • Finance
    • Insurance
    • Banks
      • GeoBanks
    • Markets
    • Press Releases
    • Personal Finance
  • World
    • America
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Americas
    • UK local news
  • Travel
    • Hotels in Georgia
    • Tours in Georgia
  • Videos
    • Promos
    • Soundslides
    • TheClinics
    • TheHoteliers
    • TheUniversities
    • TheHoteliers
    • TheClinics
    • TheUniversities
    • BestWorkplaces
    • Soundslides
    • Promos
    • Banking Forum
      • Promos
      • Soundslides
      • TheClinics
      • TheHoteliers
      • TheUniversities
  • Opinion
    • Editorial
      • Analysis
      • GORBI
      • OP-ED
      • VISA Editorial
    • Analysis
    • Gorbi
    • Book reviews
  • Tech
  • Interview
  • People
    • CityLife
    • Health & Beauty
      • Coronavirus
    • LifeStyle
    • Employment
      • MyCareer
    • Education
    • Media
    • Celebrities
  • Oil&Auto
    • Auto
    • Energy
  • EN
    • EN
    • GE
  • Home
  • Business
    • BANKS
      • GeoBanks
    • Finance
    • Insurance
    • Markets
    • Pharmacy
    • Press Releases
    • RealEstate
    • RealEstate
    • Finance
    • Insurance
    • Banks
      • GeoBanks
    • Markets
    • Press Releases
    • Personal Finance
  • World
    • America
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Americas
    • UK local news
  • Travel
    • Hotels in Georgia
    • Tours in Georgia
  • Videos
    • Promos
    • Soundslides
    • TheClinics
    • TheHoteliers
    • TheUniversities
    • TheHoteliers
    • TheClinics
    • TheUniversities
    • BestWorkplaces
    • Soundslides
    • Promos
    • Banking Forum
      • Promos
      • Soundslides
      • TheClinics
      • TheHoteliers
      • TheUniversities
  • Opinion
    • Editorial
      • Analysis
      • GORBI
      • OP-ED
      • VISA Editorial
    • Analysis
    • Gorbi
    • Book reviews
  • Tech
  • Interview
  • People
    • CityLife
    • Health & Beauty
      • Coronavirus
    • LifeStyle
    • Employment
      • MyCareer
    • Education
    • Media
    • Celebrities
  • Oil&Auto
    • Auto
    • Energy
  • EN
    • EN
    • GE
No Result
View All Result
FINCHANNEL
No Result
View All Result
Home Health&Beauty

Antibodies to Common Cold Coronaviruses Do Not Protect Against SARS-CoV-2

by The FINANCIAL
February 11, 2021
in Health&Beauty
0
Antibodies to Common Cold Coronaviruses Do Not Protect Against SARS-CoV-2
Share on FacebookShare on Twitter

The FINANCIAL — Antibodies that react to both ordinary coronaviruses and SARS-CoV-2 are common in the population but don’t neutralize the COVID-19-causing virus. Past exposure to seasonal coronaviruses (CoVs), which cause the common cold, does not result in the production of antibodies that protect against the novel coronavirus SARS-CoV-2, according to a study led by Scott Hensley, PhD, an associate professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania.

ADVERTISEMENT

According to University of Pennsylvania, prior studies have suggested that recent exposure to seasonal CoVs protects against SARS-CoV-2, the virus that causes COVID-19. However, research from Hensley’s team, published in Cell, suggests that if there is such protection, it does not come from antibodies.

“We found that many people possessed antibodies that could bind to SARS-CoV-2 before the pandemic, but these antibodies could not prevent infections,” Hensley said. “Although antibodies from prior coronavirus infections cannot prevent SARS-CoV-2 infections, it is possible that pre-existing memory B cells and T cells could potentially provide some level of protection or at least reduce the disease severity of COVID-19. Studies need to be completed to test that hypothesis.”

RelatedPosts

Brain signatures for chronic pain identified in a small group of individuals

Vigorous exercise not tied to increased risk of adverse events in rare heart condition

Global support for women’s rights massively underestimated, research shows

Clinical trial of mRNA universal influenza vaccine candidate begins

The researchers examined blood samples banked before the pandemic from hundreds of people. They found that more than 20 percent of these pre-pandemic samples carried “cross reactive” anti-CoV antibodies that could bind not only to ordinary cold-causing CoVs but also to key sites on SARS-CoV-2. However, these cross-reactive antibodies could not neutralize the infectivity of SARS-CoV-2, and were not associated with better outcomes in people who later went on to get COVID-19.

According to the University of Pennsylvania, the scientists also found from blood testing in different groups that both children and adults on average tend to have similar levels of cross-reactive anti-CoV antibodies — implying that these antibodies are not the factor that confers protection against severe COVID-19 among most children.

The COVID-19 pandemic, after more than a year of global spread, has resulted in more than 100 million reported infections, of which more than two million have been fatal. Although some risk factors, such as age, are clear enough, scientists still don’t fully understand why some people become deathly sick with COVID-19 while others escape with mild illness or even no symptoms.

Antibodies have been considered one possible explanation. Ordinary seasonal coronaviruses, of the type that cause colds, have long circulated in the human population. An obvious hypothesis is that some of the antibodies elicited by these common infections cross-react with the novel coronavirus SARS-CoV-2, providing some measure of protection, at least against severe COVID-19 illness the University of Pennsylvania notes.

In one set of analyses that Hensley and colleagues conducted, they examined blood samples collected from 263 children at the Children’s Hospital of Philadelphia, and from 168 adults at the Penn Medicine Biobank. The samples had been taken in 2017, more than two years before the SARS-CoV-2 pandemic started.

The researchers found that most of the 431 samples contained antibodies to ordinary, seasonal CoVs. Some samples, about 20 percent, contained anti-CoV antibodies that were “cross reactive” with SARS-CoV-2, binding tightly to sites on its outer spike protein and/or its nucleocapsid protein — the two coronavirus proteins that are most accessible to the immune system of infected hosts.

As the University of Pennsylvania notes, Hensley and colleagues separately analyzed blood samples banked before the pandemic from 251 people who later went on to test positive for SARS-CoV-2, and a control group of 251 people — matched for age and other relevant characteristics — who did not test positive for the novel coronavirus. Again, they found that greater than 20 percent of the pre-pandemic samples contained anti-CoV antibodies that could cross-react with the SARS-CoV-2 spike and/or nucleocapsid proteins. Yet similar proportions of the infected and uninfected groups had these cross-reactive antibodies, implying that they provided no protection against SARS-CoV-2 infection. Moreover, in the group that later went on to be infected with SARS-CoV-2, levels of cross-reactive anti-CoV antibodies in their pre-pandemic blood samples did not correlate with measures of COVID-19 severity such as the need for hospitalization or ICU care.

In a third set of tests, the researchers analyzed blood samples from 27 hospitalized COVID-19 patients, and found that levels of these cross-reactive anti-CoV antibodies were strongly boosted during the course of COVID-19 illness.

The researchers recommend that larger studies be done to definitively resolve the question of whether pre-existing anti-CoV antibodies can protect against SARS-CoV-2 viruses. They also suggest that further studies examine other types of immune response, such as the T cell response, to see if these provide a measure of cross-reactive protection following seasonal CoV infection.

In the meantime, though, they say their results suggest that the shared sites where some antibodies bind both to seasonal coronaviruses and to SARS-CoV-2 are generally not vulnerable sites where SARS-CoV-2 can be neutralized.

The co-first authors of the study were Elizabeth Anderson, Eileen Goodwin, and Anurag Verma. The study was a collaboration including not only Hensley’s laboratory but also the Penn Medicine laboratories of Paul Bates PhD, a professor of Microbiology, Michael Betts, PhD, a professor of Microbiology, Sara Cherry PhD, a professor of Pathology and Laboratory Medicine, Alex Huang, MD, an instructor of Hematology-Oncology, Nuala Meyer, MD, MS, an associate professor of Pulmonary and Critical Care Medicine, Daniel Rader MD, the Seymour Gray Professor of Molecular Medicine and chair of the Department of Genetics, and E. John Wherry, PhD, chair of Systems Pharmacology and Translational Therapeutics and director of the Penn Institute of Immunology.

Funding was provided by the National Institutes of Health and philanthropic support from Philadelphia 76ers star player Joel Embiid and managing partners Josh Harris and David Blitzer, and Philadelphia Eagles owner Jeffrey Lurie.

Tags: according to a study led by Scott Hensleyan associate professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania.antibodiesAntibodies that react to both ordinary coronaviruses and SARS-CoV-2 are common in the population but don’t neutralize the COVID-19-causing virus. Past exposure to seasonal coronaviruses (CoVs)coronavirusescross-reactive anti-CoV antibodiesdoes not result in the production of antibodies that protect against the novel coronavirus SARS-CoV-2PhDsars-cov-2which cause the common cold
ADVERTISEMENT
The FINANCIAL

The FINANCIAL

Since 2005

Related Posts

First wiring map of neurons in insect brain complete
Health&Beauty

Brain signatures for chronic pain identified in a small group of individuals

by The FINANCIAL
May 22, 2023
0

This X-ray shows two recording devices implanted in the shoulders and recording electrodes placed in the brain.Prasad Shirvalkar, M.D., Ph.D.,...

Read more
4 Small Steps for a Healthier Heart

Vigorous exercise not tied to increased risk of adverse events in rare heart condition

May 20, 2023
The Best Time of Year to Make a Life Decision

Global support for women’s rights massively underestimated, research shows

May 16, 2023

Clinical trial of mRNA universal influenza vaccine candidate begins

May 15, 2023
Next Post
Drug trial that could improve respiratory recovery from COVID-19 now underway

Drug trial that could improve respiratory recovery from COVID-19 now underway

Please login to join discussion
ADVERTISEMENT
  • Trending
  • Comments
  • Latest
Find Social Security Number by Name Free

Find Social Security Number by Name Free

November 23, 2022
Most Northwest Drivers Aren’t Worried about Car Prowls

The Illinois-based insurer remains the largest US private auto writer

May 8, 2023
Humana shares on the up as earnings show Medicare growth

Humana shares on the up as earnings show Medicare growth

May 8, 2023
How to Check KRA Pin Using ID Number

How to Check KRA Pin Using ID Number

June 25, 2018
EasyJet to fly to London from Stockholm Arlanda

The London Diplomatic List, Addresses, Contacts & Working Hours

January 23, 2023
How to optimize business costs with Intranet implementation?

Protected: 5 Key Advantages of Contact Center Solutions Every Business Must Know

May 30, 2023
New direction in the construction and development market of Georgia – “Prestige” series from “Maqro Construction”

New direction in the construction and development market of Georgia – “Prestige” series from “Maqro Construction”

May 26, 2023
Long-term international migration, provisional: year ending December 2022

Long-term international migration, provisional: year ending December 2022

May 26, 2023
putin_copy_copy.jpg

Blow for Putin as UK marks one year free from Russian gas

May 25, 2023
About a third of Americans would tell a high schooler seeking career advice to enter a STEM-related field

Recruitment firms are not effective if you want to make a big career change

May 25, 2023

Popular Last 24h

  • Find Social Security Number by Name Free

    Find Social Security Number by Name Free

    0 shares
    Share 0 Tweet 0
  • The London Diplomatic List, Addresses, Contacts & Working Hours

    0 shares
    Share 0 Tweet 0
  • The Illinois-based insurer remains the largest US private auto writer

    0 shares
    Share 0 Tweet 0
  • A new study has named Montana the best state in America to start a business

    0 shares
    Share 0 Tweet 0
  • Swedish banks’ commercial property problem loans lowest in Europe – EBA

    0 shares
    Share 0 Tweet 0
  • Recruitment firms are not effective if you want to make a big career change

    0 shares
    Share 0 Tweet 0
  • Memorandum between the “Toradze Foundation” and “Georgian Chanting Foundation” has been signed

    0 shares
    Share 0 Tweet 0

LATEST POSTS

How to optimize business costs with Intranet implementation?

Protected: 5 Key Advantages of Contact Center Solutions Every Business Must Know

May 30, 2023
New direction in the construction and development market of Georgia – “Prestige” series from “Maqro Construction”

New direction in the construction and development market of Georgia – “Prestige” series from “Maqro Construction”

May 26, 2023
Long-term international migration, provisional: year ending December 2022

Long-term international migration, provisional: year ending December 2022

May 26, 2023
putin_copy_copy.jpg

Blow for Putin as UK marks one year free from Russian gas

May 25, 2023
About a third of Americans would tell a high schooler seeking career advice to enter a STEM-related field

Recruitment firms are not effective if you want to make a big career change

May 25, 2023
Home values in U.S. decline for second month as competition eases

Understanding The True Cost of Buying a Home Warranty

May 25, 2023
Formal Credit Channels Remain a Double-Edged Sword for Consumers

Formal Credit Channels Remain a Double-Edged Sword for Consumers

May 25, 2023
Hassan Jameel

Protected: Abdul Latif Jameel Energy’s FRV Expands Operations in Europe

May 23, 2023
First wiring map of neurons in insect brain complete

Brain signatures for chronic pain identified in a small group of individuals

May 22, 2023
New York Allows Sale Of Alcoholic Beverages During Coronavirus Shutdown As Market Shrinks To $528 Billion

Scrapping retained EU red tape on wine to unlock £180 million

May 21, 2023

LATEST INTERVIEWS

“EU membership might attract European banks and other financial institutions to enter Georgia” – NBG Vice Governor Papuna Lezhava

“EU membership might attract European banks and other financial institutions to enter Georgia” – NBG Vice Governor Papuna Lezhava

by The FINANCIAL
May 15, 2023
0

“As a member of the ProCredit Group, we provide significant advantages to SME’s, by partnering with EU organizations” – Giorgi Kardenakhlishvili, Head of Medium Business Development, ProCredit Bank Georgia

“As a member of the ProCredit Group, we provide significant advantages to SME’s, by partnering with EU organizations” – Giorgi Kardenakhlishvili, Head of Medium Business Development, ProCredit Bank Georgia

by The FINANCIAL
May 15, 2023
0

‘Russia cannot be treated as a reasonable and reliable trade partner

‘Russia cannot be treated as a reasonable and reliable trade partner

by The FINANCIAL
February 13, 2023
0

We should increase our joint efforts to assist the growing tech sector here in Georgia

We should increase our joint efforts to assist the growing tech sector here in Georgia

by The FINANCIAL
February 13, 2023
0

‘Georgia has much to offer to UK investors

‘Georgia has much to offer to UK investors

by The FINANCIAL
February 13, 2023
0

‘The best way for the Georgian economy to prosper is to join the EU

‘The best way for the Georgian economy to prosper is to join the EU

by The FINANCIAL
February 13, 2023
0

‘The Kremlin wants Georgia to fail or abandon its European path

‘The Kremlin wants Georgia to fail or abandon its European path

by The FINANCIAL
February 13, 2023
0

Russian Patriarch Kirill Says Dying In Ukraine ‘Washes Away All Sins’

Interview: Why Putin Might Prefer A Stalemate To Going Nuclear On Ukraine

by The FINANCIAL
October 22, 2022
0

Newsletter

ADVERTISEMENT

GET IN TOUCH

E-mail your company news at:

news (at) financial.ge Letters to the Editor: editor (at) finchannel.com

Local Marketing contact:

(+99532) 2252 275 | 76 EXT: 1 (+995 558) 03 03 03 (mobile) marketing (at) finchannel.com

Requests from abroad:

(+99532) 2252 275 | 76 EXT: 7 (+995599) 96 52 52 Email: zviadi (@) finchannel.com Contact video editor: E-mail: video (at) financial.ge

Postal address: 17 Mtskheta str. Tbilisi, Georgia 0179 The FINANCIAL

RESOURCE

  • Work at the FINANCIAL
  • ePaper
  • Advertise in The FINANCIAL
  • Access ePaper
  • Guest posts
  • Contributed articles
  • AmericanStockNews
  • Coupon Codes
  • GLOSSY MAG
American Culture Center
ACC Partner

GUIDEBOOK

  • Meet our team
  • Invest in Georgia
  • Become contributor
  • Archive

FOLLOW US

  • Facebook
  • Twitter
  • Google+
  • Youtube
No Result
View All Result
  • Home
  • Business
    • BANKS
      • GeoBanks
    • Finance
    • Insurance
    • Markets
    • Pharmacy
    • Press Releases
    • RealEstate
    • RealEstate
    • Finance
    • Insurance
    • Banks
      • GeoBanks
    • Markets
    • Press Releases
    • Personal Finance
  • World
    • America
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Europe
    • Georgia
      • Media
    • Ukraine
    • Americas
    • UK local news
  • Travel
    • Hotels in Georgia
    • Tours in Georgia
  • Videos
    • Promos
    • Soundslides
    • TheClinics
    • TheHoteliers
    • TheUniversities
    • TheHoteliers
    • TheClinics
    • TheUniversities
    • BestWorkplaces
    • Soundslides
    • Promos
    • Banking Forum
      • Promos
      • Soundslides
      • TheClinics
      • TheHoteliers
      • TheUniversities
  • Opinion
    • Editorial
      • Analysis
      • GORBI
      • OP-ED
      • VISA Editorial
    • Analysis
    • Gorbi
    • Book reviews
  • Tech
  • Interview
  • People
    • CityLife
    • Health & Beauty
      • Coronavirus
    • LifeStyle
    • Employment
      • MyCareer
    • Education
    • Media
    • Celebrities
  • Oil&Auto
    • Auto
    • Energy
  • EN
    • EN
    • GE

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.